Octagam 10% - Business-News-Today.com

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

A heavy-lift vessel installs an offshore converter platform as Larsen & Toubro expands its European renewable-energy infrastructure pipeline through the ultra-mega TenneT offshore wind framework. Representative image.

Did Larsen & Toubro really win Rs 55,000Cr order? Official TenneT filing points to a different figure

A smart-glasses engineering workspace reflects Magic Leap’s 269 planned job cuts as the augmented reality pioneer exits first-party devices and pivots towards supplying waveguides and optical technology for artificial intelligence glasses. Representative image.

Magic Leap layoffs rise to 269 as augmented reality pioneer abandons first-party devices

Representative image showing large-scale iron ore mining operations, reflecting investor focus on Rio Tinto plc’s capital intensity, iron ore margins, and balance-sheet pressures following its 2025 results and share price decline.

Fortescue (ASX: FMG) shares fall as $525m Iron Bridge impairment overshadows record shipments

CBIZ to be taken private by Grant Thornton in largest US accounting M&A in 25+ years

Read More

Pharma Industry News

Octapharma gets Octagam 10% FDA approval for adult dermatomyositis

Octapharma USA has secured approval for Octagam 10% [Immune Globulin Intravenous (Human)] from the US Food and Drug…

July 20, 2021

web analytics